Welcome Wondros Family and
Friends! We are beta testing and need
your help improving this product.
Share Feedback
Information provided by:
Acerta Pharma BV
Last updated:
11/18/2022
Trial identifier:
NCT04529772
DisclaimerBrief summary:
Phase 3 randomized, double-blind, placebo-controlled, study assessing the efficacy and safety of acalabrutinib plus rituximab,cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) vs placebo plus R-CHOP in subjects ≤70 years of age with previously untreated non-germinal center diffuse large B-cell lymphoma.
Glossary term:
Glossary term:
Glossary term:
Glossary term:
Glossary term:
Glossary term:
Glossary term:
Research Site
Grand Rapids, Michigan, United States, 49503
Research Site
Portland, Oregon, United States, 97239
Research Site
Orange, California, United States, 92868
Research Site
Denver, Colorado, United States, 80218
Research Site
Fort Myers, Florida, United States, 33901
Research Site
West Palm Beach, Florida, United States, 33401
Research Site
Billings, Montana, United States, 59102
Research Site
Omaha, Nebraska, United States, 68198
Research Site
Nashville, Tennessee, United States, 37203
Research Site
Fort Worth, Texas, United States, 76104
Research Site
New York, New York, United States, 10065
Research Site
Pittsburgh, Pennsylvania, United States, 15212
Research Site
Lubbock, Texas, United States, 79410
Research Site
Portland, Oregon, United States, 97213
Research Site
Tucson, Arizona, United States, 85711
Research Site
New York, New York, United States, 10028
Research Site
Norwich, Connecticut, United States, 06360
Research Site
Chattanooga, Tennessee, United States, 37404
Research Site
Little Rock, Arkansas, United States, 72205
Research Site
Miami, Florida, United States, 33176
Research Site
Albany, New York, United States, 12208
Research Site
Salem, Virginia, United States, 24153
Research Site
Wichita, Kansas, United States, 67214
Research Site
New Orleans, Louisiana, United States, 70121
Research Site
Aurora, Colorado, United States, 80012
Research Site
Saint Petersburg, Florida, United States, 33705-1449
Research Site
Tallahassee, Florida, United States, 32308-5304
Research Site
Fort Wayne, Indiana, United States, 46845
Research Site
Des Moines, Iowa, United States, 50309
Research Site
Louisville, Kentucky, United States, 40207
Research Site
Kansas City, Missouri, United States, 64132
Research Site
Saint Louis, Missouri, United States, 63129
Research Site
Stony Brook, New York, United States, 11795
Research Site
Eugene, Oregon, United States, 97401
Research Site
Fort Sam Houston, Texas, United States, 78234
Research Site
Nyack, New York, United States, 10960
Research Site
Irvine, California, United States, 92618
Research Site
Duluth, Minnesota, United States, 55802
Glossary term:
October 08, 2020
Glossary term:
August 31, 2026
AstraZeneca Clinical Study Information Center
1-877-240-9479
information.center@astrazeneca.com
Glossary term: